mental health, psychiatry and mental health, journals on mental health, mental health journals, journals mental health
journals for mental health, best journals for mental health, mental health journals uk, journals on psychiatry
journals of psychiatry, psychiatry journals, asean, journal
Google Scholar citation report
Citations : 934

ASEAN Journal of Psychiatry received 934 citations as per google scholar report

ASEAN Journal of Psychiatry peer review process verified at publons
Journal Name ASEAN Journal of Psychiatry (MyCite Report)  
Total Publications 32
Total Citations 16
Total Non-self Citations 12
Yearly Impact Factor 0.053
5-Year Impact Factor 0.104
Immediacy Index 0.000
Cited Half-life 2.7
H-index 3
Social Sciences Medical & Health Sciences
Q3 Q2

Letter to the Editor - ASEAN Journal of Psychiatry (2021)


Department of Psychiatry, University of Occupational and Environmental Health, Kitakyushu, Fukuoka, Japan

*Corresponding Author:

Reiji Yoshimura, Department of Psychiatry, University of Occupational and Environmental Health, Kitakyushu, Fukuoka, Japan, Email: [email protected]

Received: 14-Sep-2021 Published: 15-Oct-2021


Peripheral levels of InterLeukin-6 (IL-6) play an important role in the pathophysiology of Major Depression (MD) [1]. Higher plasma IL-6 activity is related to refractory depression, and its levels might be a predictor of the response to selective serotonin reuptake inhibitors or serotonin and norepinephrine reuptake inhibitors [2]. Peripheral levels of IL-6 are reduced after recovery from MD [3]. Brain-Derived Neurotropic Factor (BDNF) is also associated with the pathophysiology of MD [4,5]. Peripheral levels of BDNF in patients with MD are reduced, and are increased by the use of antidepressants and electroconvulsive therapy [6,7]. These findings suggest that peripheral levels of IL-6 and BDNF may be useful biomarkers for recovery from MD. Till date, no reports have demonstrated that serum levels of IL-6 and BDNF can predict the Return To Work (RTW) in patients with MD. We investigated the relationship between serum levels of IL-6 and BDNF at baseline (T0) and at week 8 (T8), and the outcome of RTW in patients with MD. This study comprised 24 patients who met the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) criteria for MD (M/F: 14/10, Age: 29-57 years). The severity of depressive state was evaluated using the Hamilton Rating Scale for Depression (HAMD) at T0 and T8, following treatment with antidepressants. All patients achieved remission within week 12 (T12). The patients succeeding in RTW within 6 months following remission were categorized as the succeeding group, whereas the others were categorized as the failure group. Blood samples were taken at 7:00 am before breakfast (at least 12 hrs after the last medication) at T0 and T8, following treatment with antidepressants; 15 ml of venous blood was drawn after the patient had rested overnight. The serum samples were separated in a centrifuge (2000 g, 10 min, and 4°C) and stored at −80°C until assay. Serum levels of IL-6 and BDNF were measured using ELISA [8]. The study protocol was approved by the Ethics Committee of the University of Occupational and Environmental Health, Kitakyushu, Japan (approval number: H25-13; May 8, 2013) and was conducted while upholding its ethical standards. All participants signed an informed consent document explaining the study protocol and the potential risks involved. No differences were found in age, sex, HAMD scores, serum IL-6 levels, and serum BDNF levels between the succeeding and failure groups (Table 1).

Table 1: Demographics of the succeeding group and the failure group

Succeeding group Failure group p-value
Age 45 (39-51) 43 (38-51) 0.86
Female (%) 36 (%) 50 (%) 0.68
HAMD 0 W 21 (19-23) 20 (18-21) 0.30
BDNF 0 W 5.9 (4.1-7.4) 7.8 (5.9-9.2) 0.095
IL-6 0 W 1.2 (0.8-2.1) 1.4 (0.9-1.7) 0.81
BDNF (0 W-8 W) -0.2 (-0.7-0.2) 0.5 (-0.7-1.3) 0.70
IL-6 (0 W-8 W) 0 (-0.2-0.3) 0.3 (0.1-0.5) 0.26

Logistic regression analysis was also performed with RTW success or failure as the objective variable. Age, sex, changes in serum IL-6 levels, and serum BDNF levels were independent of RTW (Table 2).

Table 2: Odds ratios of each variable

Odds ratio (95% CI) p-value
Age 0.98 (0.89-1.09) 0.76
Sex (Female) 1.34 (0.23-7.79) 0.75
BDNF (0 W)-8 W) 1.09 (0.59-2.03) 0.79
IL-6 (0 W-8 W) 5.49 (0.31-97.4) 0.25

The preliminary results indicate that peripheral levels of IL-6 and BDNF during the acute phase of MD did not predict the success or failure of RTW within 6 months following remission. Further studies using a larger sample and longer follow-up must be performed to confirm the preliminary results.

Conflict of Interest Statement

The authors declare that they have no competing interests. This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.


Global Tech Summit
Get the App